Roche Holding AG has acquired GeneWEAVE BioSciences for up to $425m in order to get its hands on the latter''s "Smarticles" technology, which is being developed to help tackle the problem of antibiotic resistance.
Privately held GeneWEAVE, based in Los Gatos, California, is the developer of an innovative class of molecular diagnostics, which it...







